Palladium Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $14.9M | Sell |
30,435
-99
| -0.3% | -$45.3K | 0.66% | 49 |
|
|
2021
Q4 | $14.2M | Sell |
30,534
-50
| -0.2% | -$21K | 0.58% | 51 |
|
|
2021
Q3 | $11.4M | Sell |
30,584
-132
| -0.4% | -$50.2K | 0.52% | 55 |
|
|
2021
Q2 | $11.7M | Sell |
30,716
-89
| -0.3% | -$34K | 0.55% | 52 |
|
|
2021
Q1 | $11.1M | Sell |
30,805
-54
| -0.2% | -$17.4K | 0.55% | 52 |
|
|
2020
Q4 | $9.91M | Sell |
30,859
-427
| -1% | -$131K | 0.55% | 53 |
|
|
2020
Q3 | $8.4M | Sell |
31,286
-1,996
| -6% | -$537K | 0.53% | 50 |
|
|
2020
Q2 | $8.75M | Sell |
33,282
-303
| -0.9% | -$80.8K | 0.6% | 50 |
|
|
2020
Q1 | $7.63M | Sell |
33,585
-243
| -0.7% | -$66.2K | 0.63% | 45 |
|
|
2019
Q4 | $10.2M | Sell |
33,828
-1,970
| -6% | -$542K | 0.66% | 43 |
|
|
2019
Q3 | $9.81M | Buy |
35,798
+1,069
| +3% | +$293K | 0.69% | 47 |
|
|
2019
Q2 | $9.8M | Sell |
34,729
-209
| -0.6% | -$57.1K | 0.68% | 44 |
|
|
2019
Q1 | $10M | Sell |
34,938
-495
| -1% | -$143K | 0.72% | 43 |
|
|
2018
Q4 | $9.31M | Sell |
35,433
-365
| -1% | -$100K | 0.74% | 40 |
|
|
2018
Q3 | $9.81M | Sell |
35,798
-268
| -0.7% | -$69.6K | 0.67% | 48 |
|
|
2018
Q2 | $8.58M | Sell |
36,066
-718
| -2% | -$166K | 0.62% | 52 |
|
|
2018
Q1 | $8.08M | Sell |
36,784
-614
| -2% | -$144K | 0.6% | 53 |
|
|
2017
Q4 | $8.41M | Sell |
37,398
-710
| -2% | -$151K | 0.61% | 51 |
|
|
2017
Q3 | $7.24M | Sell |
38,108
-606
| -2% | -$115K | 0.55% | 53 |
|
|
2017
Q2 | $7.28M | Sell |
38,714
-1,553
| -4% | -$279K | 0.58% | 52 |
|
|
2017
Q1 | $6.66M | Sell |
40,267
-4,020
| -9% | -$639K | 0.54% | 55 |
|
|
2016
Q4 | $6.37M | Sell |
44,287
-542
| -1% | -$72.6K | 0.54% | 55 |
|
|
2016
Q3 | $5.62M | Sell |
44,829
-360
| -0.8% | -$46.5K | 0.49% | 61 |
|
|
2016
Q2 | $5.93M | Sell |
45,189
-1,135
| -2% | -$155K | 0.54% | 58 |
|
|
2016
Q1 | $6.44M | Sell |
46,324
-1,699
| -4% | -$227K | 0.59% | 53 |
|
|
2015
Q4 | $6.7M | Sell |
48,023
-1,142
| -2% | -$157K | 0.62% | 50 |
|
|
2015
Q3 | $6.88M | Sell |
49,165
-732
| -1% | -$110K | 0.68% | 46 |
|
|
2015
Q2 | $8.19M | Buy |
49,897
+5,087
| +11% | +$813K | 0.73% | 40 |
|
|
2015
Q1 | $6.92M | Sell |
44,810
-3,154
| -7% | -$449K | 0.59% | 59 |
|
|
2014
Q4 | $6.03M | Sell |
47,964
-1,385
| -3% | -$171K | 0.52% | 64 |
|
|
2014
Q3 | $5.9M | Sell |
49,349
-595
| -1% | -$68.2K | 0.53% | 62 |
|
|
2014
Q2 | $5.38M | Sell |
49,944
-224
| -0.4% | -$23.1K | 0.48% | 65 |
|
|
2014
Q1 | $4.99M | Buy |
50,168
+430
| +0.9% | +$38.9K | 0.46% | 66 |
|
|
2013
Q4 | $4.59M | Sell |
49,738
-319
| -0.6% | -$28.3K | 0.44% | 72 |
|
|
2013
Q3 | $4.18M | Buy |
50,057
+475
| +1% | +$40.7K | 0.42% | 75 |
|
|
2013
Q2 | $4.06M | Buy |
+49,582
| New | +$3.71M | 0.43% | 75 |
|
Other funds holding ELV
Palladium Partners's ELV Position: Q1 2022 in Review
Palladium Partners reduced its Elevance Health (ELV) stake by 0.32% in Q1 2022, selling an estimated $45.3K and leaving 30,435 shares worth $14.9M. The position accounts for 0.66% of the portfolio, ranked #49.
Palladium Partners first reported a position in ELV in Q2 2013 and has held it in 36 quarters since. 1,419 funds tracked by Wall St. Rank hold ELV as of Q1 2022.
- Palladium Partners held 30,435 shares of Elevance Health worth $14.9M as of Q1 2022.
- Palladium Partners sold 99 Elevance Health shares in Q1 2022, an estimated $45.3K.
- Elevance Health made up 0.66% of Palladium Partners's portfolio in Q1 2022, its #49 holding.
- Palladium Partners first reported a position in Elevance Health in Q2 2013 and has held it in 36 quarters since.
- 1,419 funds tracked by Wall St. Rank held Elevance Health as of Q1 2022.
Based on Palladium Partners's 13F filing for Q1 2022, filed 26 Apr 2022.